Reminder of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest
and Foreign Components
On July 10, 2019, NIH released an announcement on “Reminders of NIH Policies on Other Support and on Policies
related to Financial Conflicts of Interest and Foreign Components” to remind the extramural community about the
need to report foreign activities through documentation of other support, foreign components, and financial conflict
of interest to prevent scientific, budgetary, or commitment overlap. NIH has long required full transparency for all
research activities both domestic and foreign and does not consider these clarifications to be changes in policy.
All faculty are encouraged to go to the following link as a reminder of this policy:
Reference Letters vs. Letters of Support: What’s the Difference?
Reference letters and letters of support provide key information for reviewers and NIH staff. Check out the attached
table for an overview of when each letter is used, who writes them, and what should be included.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Reference Letters vs.pdf?ver=2019-09-23-075716-940
i2E Entrepreneurial Summit on Friday, November 15, 2019 at 9:00 am – 1:00 pm at the Reed Conference
Center, Midwest City 73110. See attached document for more complete information.
Don’t Forget to Link Your ORCID iD to Your eRA Commons Profile
Graduate students to senior scientists are encouraged to register for an ORCID account (https://orcid.org/register)
and link it to their eRA Commons personal profile
Starting October 1, 2019, ORCID identifiers will be required for individuals supported by institutional research training,
career development, and other research education awards. xTrain appointments will not be accepted for agency review
if potential appointees do not have an ORCID iD linked to their eRA personal profile. ORCID iDs will also be required for
PD/PIs on individual fellowship and career development applications submitted for due dates on or after January 25, 2020.
The Office of Technology Development will offer the Innovation to Impact Series Session 2
“Aligning Your Research With Industry.” Learn how to gather useful insights from the market; Common customer discovery
mistakes; and Funding to support market discovery. Meredith Wilkerson, Licensing Officer -Life Sciences and Andrew
Pollock, Interim Exec. Director of OTD will be presenting.
This session will occur on September 25th from Noon- 1:00 pm in Biomedical Research Center Building, Room 103.
Lunch will be provided.
Please RSVP to firstname.lastname@example.org by September 23rd. Space is limited to the first 15 attendees.
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Small
Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) experts are c
oming to Oklahoma City to conduct an SBIR Outreach Event.
Wednesday, September 25th from 9:00 am to 4:00 pm at the OUHSC PHF Conference Center.
See the attached document for additional information.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/NIH Contract SBIR Topics.docx?ver=2019-08-18-153311-077
Office of Technology Development presents a third opportunity to engage with industry
(for more information go to http://www.ou.edu/otd/ICO, or email email@example.com for specific submission details):
Almirall is looking to sponsor academic research for target identification, validation, and/or to advance pre-clinical therapeutic
opportunities into clinical settings for “novel targets, pathways, or therapeutic candidates relating to chronic immune-inflammatory
disease” (expiration 9/30/19). Funding up to $250K per project to be awarded by Almirall in November 2019.
Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS
The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th. Abstracts must be
received by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November 15, 2019 at the Samis Education
Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral presentations, a poster session,
and Symposia talks by P. Darrell Neufer, PhD, Professor, East Carolina University, Matthew Rodeheffer PhD, Associate
Professor, Yale University and Scott Summers, PhD, Professor and Chair, The University of Utah. For abstract submission
guidelines and to RSVP for this free event, please go to:
Please contact Katie-Hoefling@ouhsc.edu with any questions for this event.
Save the Date – ORA Noon Conference
Navigating the ORA Proposal Submission Process
Speaker(s): Caitlin Novotny, Sponsored Programs Administrator, Office of Research Administration
Offered: September 25, 2019 LIB-299 12-1pm
Overview: This session will cover the basics of proposal preparation and map out the process of submission through
the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for during the
pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies. We will
also cover topics related to proposal submission, such as grant routing forms and the systems used to submit federal grants.
The overall goal of this presentation is to provide a basic understanding of and advice on proposal preparation and submission
Notice of Pre-Application Webinar for FOAs related to the NHLBI CATALYZE Program: RFA-HL-20-022, RFA-HL-20-023,
RFA-HL-20-024, RFA-HL-20-027 and RFA-HL-20-028 (NOT-HL-19-709)
AHRQ Encourages Use of Fast Healthcare Interoperability Resources (FHIR) Standard (NOT-HS-19-020)
HEAL/NINDS Early Phase Pain Investigation Clinical Network (EPPIC-Net): Opening to applications for non-addictive pain
New to Working with the NIH Grants Process & Policies? Dont Miss the NIH Regional Seminar on Program Funding and
Grants Administration Phoenix, AZ Nov. 6-8, 2019 (NOT-OD-19-144)
Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis
and Lupus (AMP RA/SLE Program (NOT-AR-19-039)
Request for Information (RFI): Inviting comments and suggestions on the development of a prize competition for Gender
Diversity in the Biomedical Research Workforce (NOT-OD-19-141)
Request for Information (RFI): Enhancing the Clinical and Translational Science Awards (CTSA) Program
NIDDK Notice of Participation in PA-19-273, "PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small
Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
Notice of Clarification of Eligible Individuals for RFA-DK-18-024 "Predoctoral to Postdoctoral Fellow Transition Award
Notice of Clarification of Research Strategy for RFA-DK-19-010 Polycystic Kidney Disease (PKD) Research and Translation
Core Centers" (NOT-DK-19-026)
Notice of NIBIB's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers
(MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of Change of Receipt Date for RFA-HD-20-007 "The Role of Stem/Progenitor Cells in the Pathogenesis and
Treatment of Gynecologic Disorders (R21 Clinical Trial Optional)" (NOT-HD-19-026)
Notice of Intent to Publish a Funding Opportunity Announcement for Early Liver Transplantation Cohort Study
(U10 - Clinical Trial Optional) (NOT-AA-19-025)
Notice of Special Interest in High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and
the Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-19-039)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
(PAR-19-365) - Deadline
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)
(PAR-19-366) – Deadline November 13, 2019 and October 1, 2020
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) (PAR-19-367)
Deadline January 17, 2020 and May 18, 2020
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
(PAR-19-368) - Deadline October 5, 2019
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) (PAR-19-369)
Deadline October 16, 2019.
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) (PAR-19-370)
Deadline October 16, 2019.
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) (PAR-19-371)
Deadline October 12, 2019
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) (PAR-19-372)
Deadline November 6, 2019 and November 6, 2020
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
(PAR-19-374) - Deadline January 25, 2020
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
(PAR-19-375) - Deadline February 16, 2020
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-19-376)
Deadline November 19, 2019 and September 24, 2020
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation
(R01 Clinical Trial Optional) (PAR-19-377) - Deadline February 5, 2020
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences
(T32 Clinical Trial Not Allowed) (RFA-AG-20-032) – Deadline October 28, 2019
Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)
(RFA-AG-20-045) - Deadline November 4, 2019
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)
(RFA-AI-19-063) – Deadline AIDS
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)
(RFA-CA-19-042) - Deadline December 19, 2019 and July31, 2020
Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
(RFA-CA-19-056) – Deadline January 10, 2020
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
(RFA-CA-19-064) - Deadline January 15, 2020
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed)
(RFA-DA-20-010) - Deadline November 19, 2019
NIDDK Cooperative Centers of Excellence in Hematology (U54 Clinical Trial Not Allowed)
(RFA-DK-19-005) - Deadline November 21, 2019 and June 30, 2020
Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed)
(RFA-HD-20-001) - Deadline November 29, 2019
Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction
(R21 Clinical Trial Optional) (RFA-HD-20-021) – Deadline November 26, 2019
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)
(RFA-HL-20-006) - Deadline November 18, 2019 and October 15, 2020
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
(RFA-HL-20-022) - Deadline November 8, 2019 and March 9, 2020
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary
Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) (RFA-HL-20-023)
Deadline November 8, 2019 and March 9, 2020
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay
Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
(RFA-HL-20-024) - Deadline November 8, 2019 and March 9, 2020
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification
(R33 - Clinical Trial Not Allowed) (RFA-HL-20-027) – Deadline November 8, 2019 and March 9, 2020
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay
Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
(RFA-HL-20-028) - Deadline November 8, 2019 and March 9, 2020
Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed)
(RFA-HL-21-002) - Deadline March 6, 2020
Resource-Related Research Projects for Development of Animal Models and Related Materials
(R24 Clinical Trials Not-Allowed) (RFA-OD-19-027) - Deadline October 28, 2019 and January 27, 2020
American Cancer Society (ACS) – Deadline October 15, 2019 – Programs:
Research Scholar Grants
Clinician Scientist Development Grant